Praxis Precision Medicines is converting its EMBRAVE3 study of elsunersen for children suffering from a developmental disease into a single-arm study after meeting with the Food and Drug ...
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
Telix Pharmaceuticals has pointed to “promising efficacy” for its radiation therapy in a small, single arm study of patients with brain cancer. The phase 2 Ipax-Linz trial enrolled eight patients with ...
The US Food and Drug Administration’s (FDA’s) approval decision about a new treatment for non–muscle invasive bladder cancer (NMIBC) hinges on whether a single-armed trial can be trusted to adequately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results